Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,983 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bevacizumab-containing chemotherapy for non-small cell lung cancer patients: a population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research group.
Nakamura H, Satoh H, Kaburagi T, Nishimura Y, Shinohara Y, Inagaki M, Endo T, Saito T, Hayashihara K, Hizawa N, Kurishima K, Nawa T, Kagohashi K, Kishi K, Ishikawa H, Ichimura H, Hashimoto T, Sato Y, Sakai M, Kamiyama K, Matsumura T, Unoura K, Furukawa K. Nakamura H, et al. Among authors: endo t. Med Oncol. 2012 Dec;29(5):3202-6. doi: 10.1007/s12032-012-0318-5. Epub 2012 Nov 2. Med Oncol. 2012. PMID: 23117478
Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research Group.
Kurishima K, Satoh H, Kaburagi T, Nishimura Y, Shinohara Y, Inagaki M, Endo T, Saito T, Hayashihara K, Hizawa N, Nakamura H, Nawa T, Kagohashi K, Kishi K, Ishikawa H, Ichimura H, Hashimoto T, Sato Y, Sakai M, Kamiyama K, Matsumura T, Unoura K, Fukuoka T, Uchiumi K, Nomura A, Furukawa K. Kurishima K, et al. Among authors: endo t. Mol Clin Oncol. 2013 Sep;1(5):828-832. doi: 10.3892/mco.2013.154. Epub 2013 Jul 23. Mol Clin Oncol. 2013. PMID: 24649255 Free PMC article.
The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma.
Konno S, Hizawa N, Makita H, Shimizu K, Sakamoto T, Kokubu F, Saito T, Endo T, Ninomiya H, Iijima H, Kaneko N, Ito YM, Nishimura M; J-Blossom Study Group. Konno S, et al. Among authors: endo t. Pharmacogenet Genomics. 2014 May;24(5):246-55. doi: 10.1097/FPC.0000000000000043. Pharmacogenet Genomics. 2014. PMID: 24681963 Clinical Trial.
Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small-cell lung cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA).
Kawaguchi T, Ando M, Asami K, Okano Y, Fukuda M, Nakagawa H, Ibata H, Kozuki T, Endo T, Tamura A, Kamimura M, Sakamoto K, Yoshimi M, Soejima Y, Tomizawa Y, Isa S, Takada M, Saka H, Kubo A. Kawaguchi T, et al. Among authors: endo t. J Clin Oncol. 2014 Jun 20;32(18):1902-8. doi: 10.1200/JCO.2013.52.4694. Epub 2014 May 19. J Clin Oncol. 2014. PMID: 24841974 Clinical Trial.
S-1-containing chemotherapy for patients with non-small-cell lung cancer: A population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research group.
Inagaki M, Shinohara Y, Kaburagi T, Endo T, Homma S, Hizawa N, Kishi K, Nakamura H, Hayashihara K, Saito T, Kurishima K, Ishikawa H, Ichimura H, Nawa T, Kikuchi N, Miyazaki K, Kodama T, Satoh H, Furukawa K. Inagaki M, et al. Among authors: endo t. Mol Clin Oncol. 2016 Jun;4(6):1025-1030. doi: 10.3892/mco.2016.826. Epub 2016 Mar 21. Mol Clin Oncol. 2016. PMID: 27284438 Free PMC article.
Acquired EGFR T790M Mutation After Relapse Following EGFR-TKI Therapy: A Population-based Multi-institutional Study.
Kaburagi T, Kiyoshima M, Nawa T, Ichimura H, Saito T, Hayashihara K, Yamada H, Satoh H, Endo T, Inage Y, Saito K, Inagaki M, Hizawa N, Sato Y, Ishikawa H, Sakai M, Kamiyama K, Kikuchi N, Nakamura H, Furukawa K, Kodama T, Yamashita T, Nomura A, Yoshida S. Kaburagi T, et al. Among authors: endo t. Anticancer Res. 2018 May;38(5):3145-3150. doi: 10.21873/anticanres.12577. Anticancer Res. 2018. PMID: 29715155
Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes.
Nakamura R, Inage Y, Tobita R, Yoneyama S, Numata T, Ota K, Yanai H, Endo T, Inadome Y, Sakashita S, Satoh H, Yuzawa K, Terashima T. Nakamura R, et al. Among authors: endo t. J Thorac Oncol. 2018 Jul;13(7):895-903. doi: 10.1016/j.jtho.2018.04.035. Epub 2018 May 8. J Thorac Oncol. 2018. PMID: 29751134 Free article.
Clinicopathological Features in Elderly ALK-rearranged Non-small Cell Lung Cancer Patients.
Miyazaki K, Sato S, Kodama T, Numata T, Endo T, Yamamoto Y, Shimizu K, Yamada H, Hayashihara K, Okauchi S, Satoh H, Yamada Y, Tamura T, Saito K, Kikuchi N, Kurishima K, Ishikawa H, Watanabe H, Shiozawa T, Hizawa N, Funayama Y, Hayashi S, Nakamura H, Yamashita T. Miyazaki K, et al. Among authors: endo t. In Vivo. 2020 Jul-Aug;34(4):2001-2007. doi: 10.21873/invivo.11998. In Vivo. 2020. PMID: 32606173 Free PMC article.
3,983 results